(11C)ABT-627,
2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid,
A 127722,
A 127722.5,
A 147627,
A-127722,
A-127722.5,
A-147627,
A127722,
A127722.5,
A147627,
ABT 627,
ABT-627,
ABT627,
atrasentan,
Atrasentan Hydrochloride,
Xinlay,
Atrasentan hydrochloride,
195733-43-8,
Atrasentan HCl,
Atrasentan (hydrochloride),
UNII-E4G31X93ZA,
Abbott 147627,
Atrasentan hydrochloride [USAN],
E4G31X93ZA,
ABBOT-147627,
A 147627.1,
A-147627.1,
Atrasentan hydrochloride (USAN),
(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride,
3-Pyrrolidinecarboxylicacid,4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-,hydrochloride (1:1), (2R,3R,4S)-,
D03009,
AC1L4M3I,
AC1Q3E6T,
(2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride(1:1),
CHEMBL2106068,
CTK4E1845,
DTXSID20173240,
IJFUJIFSUKPWCZ-SQMFDTLJSA-N,
HY-15403A,
CS-1373,
AN-30228,
Atrasentan hydrochloride, >=98% (HPLC),
A3201,
W-5571,
733A438,
ABT-627;ABT627;ABT 627;Abbott 147627,
(2r,3r,4s)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid hydrochloride salt,
(2R,3R,4S)-1-((Dibutylcarbamoyl)methyl)-2-(p-methoxyphenyl)-4-(3,4-(methylenedioxy)phenyl)-3-pyrrolidinecarboxylic acid, monohydrochloride,
(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxo-ethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride,
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, monohydrochloride, (2R,3R,4S)-,
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, monohydrochloride, (2R-(2alpha,3beta,4alpha)),
C29H38N2O6.ClH,
ABT-627,
KST-1A2838,
KST-1A2839,
C29-H38-N2-O6.Cl-H,
AR-1A2890,
AR-1A2891,
CID159595,
195733-43-8 (HCl),
A-127722,
2242-65-1,
22427-00-5,